13.08.2014
- Sanofi and MannKind Corporation have entered into a worldwide exclusive licensing agreement for development and commercialization of Afrezza (insulin human) Inhalation Powder, a...
30.06.2014
- The European Medicine Agency (EMA) has recommended approval of Abasria, Eli Lilly's biosimilar version of Sanofi's insulin glargine sold as Lantus. This means that the French...
16.06.2014
- The world's biggest would-be drugs merger hit a wall last month but speculation about smart ways that Pfizer could yet seal a deal with AstraZeneca remains intense. Even as talks...
29.05.2014
- US drugmaker Eli Lilly has struck a licensing deal with Sanofi that would allow its French rival to pursue regulatory approval for a non-prescription version of Lilly's erectile...
08.05.2014
- In contrast to chemicals, the global pharmaceutical industry is little plagued by market cyclicality or general economic swings. But it faces equally daunting challenges, as the...
07.05.2014
- As expected, Germany's Bayer has emerged as the winner of the race to acquire U.S. Merck's consumer care business. The $14.2 billion deal announced on May 5 is expected to close in...
30.04.2014
- French pharmaceutical producer Sanofi is looking to sell a portfolio of mature drugs that could fetch between $7 billion and $8 billion, the news agency Reuters said, quoting...
28.04.2014
- Germany's Bayer and British consumer products giant Reckitt are said to have emerged as frontrunners to win the auction for the Merck & Co consumer products unit, each reportedly...
